2146931
Project Grant
Overview
Grant Description
Sbir Phase I: Neuromodulation Device to Promote Healthy Sleeping Cycle - This Small Business Innovation Research (SBIR) Phase I project aims to provide a safe, wearable device to improve the quality of sleep. Sleep deprivation due to insomnia or other factors represents a significant health risk linked to various daily issues and later disorders in life.
The lack of sleep costs the United States an estimated $411 billion in lost productivity and wages. This novel medical technology will provide an externally worn system which delivers a combination of low risk and reversible visual and auditory impulses, enabling patients to experience brainwaves associated with the desired restorative sleep stage.
The product aims to capture a significant portion of the annual $80B global sleep aid market predominantly comprised of supplements and drugs. This Small Business Innovation Research (SBIR) Phase I project will complete prototype engineering for a patient-worn system which provides sensory stimulation in order to modulate brain waveforms during sleep.
The system utilizes controlled and safe light and sound stimuli to transpose the brainwaves associated with the desired sleeping state into the recipient's brain measured using non-invasive electrical activity (EEG). The system is based on peer-reviewed evidence that normal brain wave patterns can be effectively transposed to a subject suffering from sleep disorders for restoring normative sleep.
The Phase I project will complete the data analysis of reference patient sleep patterns, and prototype design engineering to enable pilot studies and gaining evidence in subsequent stages. This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
The lack of sleep costs the United States an estimated $411 billion in lost productivity and wages. This novel medical technology will provide an externally worn system which delivers a combination of low risk and reversible visual and auditory impulses, enabling patients to experience brainwaves associated with the desired restorative sleep stage.
The product aims to capture a significant portion of the annual $80B global sleep aid market predominantly comprised of supplements and drugs. This Small Business Innovation Research (SBIR) Phase I project will complete prototype engineering for a patient-worn system which provides sensory stimulation in order to modulate brain waveforms during sleep.
The system utilizes controlled and safe light and sound stimuli to transpose the brainwaves associated with the desired sleeping state into the recipient's brain measured using non-invasive electrical activity (EEG). The system is based on peer-reviewed evidence that normal brain wave patterns can be effectively transposed to a subject suffering from sleep disorders for restoring normative sleep.
The Phase I project will complete the data analysis of reference patient sleep patterns, and prototype design engineering to enable pilot studies and gaining evidence in subsequent stages. This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
Awardee
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Suffern,
New York
10901-3746
United States
Geographic Scope
Single Zip Code
Related Opportunity
None
Neurolight was awarded
Project Grant 2146931
worth $255,851
from National Science Foundation in September 2022 with work to be completed primarily in Suffern New York United States.
The grant
has a duration of 1 year and
was awarded through assistance program 47.084 NSF Technology, Innovation, and Partnerships.
SBIR Details
Research Type
SBIR Phase I
Title
SBIR Phase I:Neuromodulation device to promote healthy sleeping cycle
Abstract
This Small Business Innovation Research (SBIR) Phase I project aims to provide a safe, wearable device to to improve the quality of sleep. Sleep deprivation due to insomnia or other factors represents a significant health risk linked to various daily issues and later disorders in life. The lack of sleep costs the United States an estimated $411 billion in lost productivity and wages. This novel medical technology will provide an externally worn system which delivers a combination of low risk and reversible visual and auditory impulses, enabling patients to experience brainwaves associated with the desired restorative sleep stage. The product aims to capture a significant portion of the annual $80B global sleep aid market predominantly comprised of supplements and drugs.This Small Business Innovation Research (SBIR) Phase I project will complete prototype engineering for a patient worn system which provides sensory stimulation in order to modulate brain waveforms during sleep. The system utilizes controlled and safe light and sound stimuli to transpose the brainwaves associated with the desired sleeping state into the recipient’s brain measured using non invasive electrical activity (EEG). The system is based on peer-reviewed evidence that normal brain wave patterns can be effectively transposed to a subject suffering from sleep disorders for restoring normative sleep. The phase I project will complete the data analysis of reference patient sleep patterns, and prototype design engineering to enable pilot studies and gaining evidence in subsequent stages.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
Topic Code
MD
Solicitation Number
NSF 21-562
Status
(Complete)
Last Modified 9/20/22
Period of Performance
9/15/22
Start Date
8/31/23
End Date
Funding Split
$255.9K
Federal Obligation
$0.0
Non-Federal Obligation
$255.9K
Total Obligated
Activity Timeline
Additional Detail
Award ID FAIN
2146931
SAI Number
None
Award ID URI
SAI EXEMPT
Awardee Classifications
Small Business
Awarding Office
491503 TRANSLATIONAL IMPACTS
Funding Office
491503 TRANSLATIONAL IMPACTS
Awardee UEI
QMKAADETCSK5
Awardee CAGE
85RA5
Performance District
17
Senators
Kirsten Gillibrand
Charles Schumer
Charles Schumer
Representative
Michael Lawler
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| Research and Related Activities, National Science Foundation (049-0100) | General science and basic research | Grants, subsidies, and contributions (41.0) | $255,851 | 100% |
Modified: 9/20/22